Dr. Brantly was flown out of Africa to the U.S. over a week ago for further medical treatment, while Writebol came days after. Writebol is also being treated at the same hospital. They were provided with ZMapp, an experimental drug treatment, said further research. Mapp Biopharmaceutical in San Diego developed the said Ebola treatment drug, whose long-term impacts and toxicity remain unknown.